Michael J. Fox Foundation Awards $2 Million to Continue Search for Biomarkers of Parkinson’s Disease
“Biomarkers remain a priority for the Foundation because the ability to definitively diagnose PD and to measure its progression is inextricably linked to the ability to conduct better, faster clinical trials. In particular, biomarkers would greatly accelerate the development of neuroprotective therapies that could slow or stop the disease, something of tremendous importance to PD patients and our Foundation,” said Katie Hood, chief executive officer of MJFF.
In keeping with the Foundation’s commitment to keep highly promising research moving forward as efficiently as possible, four of five projects under the 2007 initiative are extensions of projects that showed distinct promise when they were funded in earlier rounds of the Biomarkers program.
A team at DiaGenic ASA in
Norbert Schuff, PhD, of Northern California Institute for Research and Education will lead a study that aims to establish objective markers of Parkinson’s disease based on magnetic resonance imaging (
The following is a complete list of researchers funded under Biomarkers 2007. Grant abstracts and researcher bios are available on the Foundation’s Web site, www.michaeljfox.org.
- “Prospective Validation of Risk Markers for the Development of Parkinson’s Disease”
Daniela Berg, MD, Neurology and Hertie-Institute of Clinical Brain
- “A Gene Expression Signature for the Early Detection of Parkinson’s disease”
Anders Lonneborg, PhD,
- “Multi-center Validation of CSF Alpha-Synuclein in Parkinson’s, Dementia with Lewy Bodies and Prion Disease”
Michael Schlossmacher, MD, FRCPC,
University of Ottawa, Canada
MRIMarkers for Parkinson’s Disease”
Norbert Schuff, PhD, Northern California Institute for Research and Education
- “Isoforms of Alpha-Synuclein as Biomarkers for Diagnosis and Progression of Parkinson’s Disease”
Jing Zhang, MD, PhD,
The Michael J. Fox Foundation has been a field leader in spearheading the search for a PD biomarker, with approximately $8.5 million in biomarker research funded to date.
Biomarkers 2007 is made possible with leadership support from The Michael J. Fox Foundation’s Board of Directors and Virginia Brooks. Additional support has been provided by the South Palm Beach Chapter NPF.